KPA to revise some irrational regulations in the Pharmaceutical Affairs Law

Published: 2002-06-27 07:00:00

Updated: 2002-06-27 07:00:00

The Korean Pharmaceutical Association (KPA) said it plans to revise some regulations of the Pharmaceutical Affairs Law which lack equilibrium and rationale compared to the Medical Law. Noting that this move is designed to fully reflect the new drug related environments, following the 2-year imple...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK